NDC 70771-1355

CARBIDOPA

Carbidopa

CARBIDOPA is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Zydus Lifesciences Limited. The primary component is Carbidopa.

Product ID70771-1355_1e51c5e1-8573-4599-90e7-5d9a4a7f3d40
NDC70771-1355
Product TypeHuman Prescription Drug
Proprietary NameCARBIDOPA
Generic NameCarbidopa
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2018-09-06
Marketing CategoryANDA / ANDA
Application NumberANDA209910
Labeler NameZydus Lifesciences Limited
Substance NameCARBIDOPA
Active Ingredient Strength25 mg/1
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 70771-1355-1

100 TABLET in 1 BOTTLE (70771-1355-1)
Marketing Start Date2018-09-06
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 70771-1355-1 [70771135501]

CARBIDOPA TABLET
Marketing CategoryANDA
Application NumberANDA209910
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2018-09-06

Drug Details

Active Ingredients

IngredientStrength
CARBIDOPA25 mg/1

OpenFDA Data

SPL SET ID:83012ccc-aba2-45bb-9326-dc30cdeb4e3b
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 260260

    • NDC Crossover Matching brand name "CARBIDOPA" or generic name "Carbidopa"

    NDCBrand NameGeneric Name
    16714-067CarbidopaCarbidopa
    40032-980CarbidopaCarbidopa
    42799-123CarbidopaCarbidopa
    43386-980CarbidopaCarbidopa
    43975-220CarbidopaCarbidopa
    51407-314CarbidopaCarbidopa
    59651-146CarbidopaCarbidopa
    63629-1932CarbidopaCarbidopa
    63629-9193CarbidopaCarbidopa
    68682-200CarbidopaCarbidopa Tablets
    70710-1221CARBIDOPACARBIDOPA
    70771-1355CARBIDOPACARBIDOPA
    25010-711Lodosyncarbidopa
    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.